CytomX Therapeutics Inc (CTMX) — Long-term Investment Intensity

Latest as of September 2021: 26.9%

CytomX Therapeutics Inc (CTMX) has a Long-term Investment Intensity of 26.9% as of September 2021. Long-term investments of $99.97 Million represent 26.9% of total assets of $371.23 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See CTMX net assets for net asset value and shareholders' equity analysis.

LT Investment Intensity

26.9%
LT Investments / Total Assets

Long-term Investments

$99.97 Million
USD

Total Assets

$371.23 Million
USD

Country

USA
NASDAQ

Annual Long-term Investment Intensity for CytomX Therapeutics Inc (None–None)

The table below presents the year-by-year Long-term Investment Intensity for CytomX Therapeutics Inc from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market value of CytomX Therapeutics Inc.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
pp = percentage points